Novavax, SK bioscience expand agreement to manufacture COVID vaccine containing Omicron variant Ruchika Sharma24 July 2022 11:00 AM ISTGaithersburg: Novavax, Inc has signed agreements with its partner, SK bioscience, for the manufacturing and supply of a version of the Novavax...
EU identifies severe allergic reactions as side effects of Novavax COVID vaccine Ruchika Sharma15 July 2022 4:30 PM ISTThe EMA said it would also update the product information for the vaccine to add unusual or decreased feeling in the skin as a new side effect.
Novavax COVID vaccine gets USFDA emergency use nod for 18 years and older Ruchika Sharma14 July 2022 12:14 PM ISTNVX-CoV2373 is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes COVID-19 disease.
Novavax COVID vaccine Nuvaxovid gets European Commission conditional nod for adolescents Ruchika Sharma6 July 2022 11:36 AM ISTNVX-CoV2373 is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes COVID-19 disease.
Novavax likely to come up with COVID vaccine targeting Omicron in Q4 Ruchika Sharma3 July 2022 12:30 PM ISTNew Delhi: Novavax Inc said on Friday it expects to provide a COVID-19 vaccine targeting Omicron in the fourth quarter as it accelerates development...
Novavax COVID vaccine Nuvaxovid recommended for expanded conditional marketing authorization in EU for adolescents Ruchika Sharma26 Jun 2022 12:30 PM ISTNVX-CoV2373 is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes COVID-19 disease.
Novavax COVID vaccine gets emergency use nod in Taiwan for adults Ruchika Sharma24 Jun 2022 11:33 AM ISTNVX-CoV2373 is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes COVID-19 disease.
Novavax COVID shot gets USFDA Advisory Committee recommendation for emergency use nod for 18 years and older Ruchika Sharma8 Jun 2022 12:14 PM ISTNVX-CoV2373 is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes COVID-19 disease.
SII to produce Novavax COVID vaccine for US Ruchika Sharma8 Jun 2022 10:00 AM ISTNew Delhi: Novavax Inc said on Tuesday that its COVID-19 vaccine initially available in the United States, if authorized, will be manufactured by the...
USFDA flags heart inflammation risk after taking Novavax COVID vaccine Ruchika Sharma4 Jun 2022 3:09 PM ISTThe FDA said it had requested Novavax to flag myocarditis and another kind of heart inflammation as an "important identified risk" in its materials.
Coronavirus: India supplies non-JnJ vaccine under Quad umbrella Ruchika Sharma21 May 2022 10:00 AM ISTBagchi did not give numbers, but Indian foreign ministry data shows that India last month sent 200,000 doses of Covovax, a version of the Novavax...
Novavax seeks Taiwan FDA emergency use nod for COVID-19 vaccine Ruchika Sharma14 May 2022 10:00 AM ISTUnited States: Novavax has announced the submission of a request for emergency use authorization to Taiwan's Food and Drug Administration for its...
